Focus Diagnostics Home
 Home  About Focus Diagnostics  Employment  Contact Us
Test Listing New Tests Test Updates Certifications Client Services Account Setup Contact Us
 
Click the controls at right to expand & collapse the search function Open the search function Close the search function
Please select the first letter of the test you are interested in viewing or
click NEW for a complete listing of our newest assays.
Enter Test Name(s) / Code(s): Test Title Description Category Search:
 
All words must appear Any word can appear    
Reference Laboratory
Tests
 
52043
AFB Susceptibility, M. avium Complex, Drug Combinations, Agar Method print

This test uses antimicrobial agent combinations and is performed by the agar proportion method. The panel incudes (the rest is in the DOS descriptor)

Panel includes
:
  Ethambutol in combination with Clarithromycin, Erythromycin and Rifampin.

In order to perform susceptibility testing and interpret test results, the identification of the isolate is required.

This test is not approved for New York patient testing.



Please see the following technical sheet for more information:
 Antimicrobial Testing

Agar Dilution
By report
Pure culture safely contained.
2-28° C
21 to 28 days
87190 x 4
 
 
First FDA Clearance of a 2009 H1N1 Test Given to Focus Diagnostics


FDA Issues Another Emergency Use Authorization for Commercial H1N1 Flu Test to Quest Diagnostics’ Focus Diagnostics


Focus Diagnostics provides the first commercial test for detecting the 2009 H1N1 influenza virus that the FDA has authorized for emergency use.


Focus Diagnostics receives NYSDOH exemption for Diagnostic Immunology and Serology testing services


Focus Diagnostics Launches Laboratory Test for Chikungunya Virus


 
   
Back to top  
   
©2010 - Focus Diagnostics - All Rights Reserved - Site Revision ID: WEB.FOCUSDX.C3 - Privacy Policy - Site Map